Endometriosis Drug Market Report

China Endometriosis Drug Industry Market Research Report 2023-2029

  • POSTDATE：Oct 07, 2023
  • PAGES：149
  • REPORT CODE：GMM1835020
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Endometriosis Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • AbbVie

    • Endoceutics

    • United Pharmaceuticals

    • Roivant Sciences

    • Pfizer

    • Neurocrine Biosciences

    • SYNG Pharmaceuticals

    • PregLem

    • Debiopharm

    • Euroscreen

    • Astellas Pharma

    • Speciality European Pharma

    • Addex Therapeutics

    • Isifer

    • Repros Therapeutics

    • ElexoPharm

    • AstraZeneca

    • SK Chemicals

    • Forendo Pharma

    • Kissei Pharmaceutical

    • Takeda

    • Orphagen Pharmaceuticals

    • Bayer HealthCare

    • Philogen

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Endometriosis Drug Market Overview 2018-2029

    • 1.1 China Endometriosis Drug Industry Development Overview

    • 1.2 China Endometriosis Drug Industry Development History

    • 1.3 China Endometriosis Drug Industry Market Size (2018-2029)

    • 1.4 China Endometriosis Drug Market Analysis by Type from Production Side

      • 1.4.1 China Endometriosis Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Endometriosis Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Endometriosis Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Endometriosis Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Endometriosis Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Endometriosis Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Endometriosis Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Endometriosis Drug Market Analysis by Region

      • 1.6.1 North China Endometriosis Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Endometriosis Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Endometriosis Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Endometriosis Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Endometriosis Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Endometriosis Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Endometriosis Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Endometriosis Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Endometriosis Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Endometriosis Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Endometriosis Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Endometriosis Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Endometriosis Drug Industry Development

    Chapter 3 Endometriosis DrugIndustry Chain Analysis

    • 3.1 Endometriosis Drug Industry Chain

    • 3.2 Endometriosis Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Endometriosis Drug Market

    • 3.3 Endometriosis Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Endometriosis Drug Market

    Chapter 4 China Endometriosis Drug Market, by Type

    • 4.1 China Endometriosis Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Endometriosis Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Endometriosis Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Endometriosis Drug Production Volume and Growth Rate of Type 1

      • 4.5.2 China Endometriosis Drug Production Volume and Growth Rate of Type 2

      • 4.5.3 China Endometriosis Drug Production Volume and Growth Rate of Type 3

    Chapter 5 China Endometriosis Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Endometriosis Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Endometriosis Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Endometriosis Drug Market Size and Growth Rate of Application 1

      • 5.5.2 China Endometriosis Drug Market Size and Growth Rate of Application 2

      • 5.5.3 China Endometriosis Drug Market Size and Growth Rate of Application 3

    Chapter 6 China Endometriosis Drug Market, by Region

    • 6.1 China Endometriosis Drug Production Volume and Production Value, by Region

    • 6.2 China Endometriosis Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Endometriosis Drug Market Analysis

    • 7.1 North China Endometriosis Drug Market, by Type

    • 7.2 North China Endometriosis Drug Market, by Application

    Chapter 8 Central China Endometriosis Drug Market Analysis

    • 8.1 Central China Endometriosis Drug Market, by Type

    • 8.2 Central China Endometriosis Drug Market, by Application

    Chapter 9 South China Endometriosis Drug Market Analysis

    • 9.1 South China Endometriosis Drug Market, by Type

    • 9.2 South China Endometriosis Drug Market, by Application

    Chapter 10 East China Endometriosis Drug Market Analysis

    • 10.1 East China Endometriosis Drug Market, by Type

    • 10.2 East China Endometriosis Drug Market, by Application

    Chapter 11 Northeast China Endometriosis Drug Market Analysis

    • 11.1 Northeast China Endometriosis Drug Market, by Type

    • 11.2 Northeast China Endometriosis Drug Market, by Application

    Chapter 12 Southwest China Endometriosis Drug Market Analysis

    • 12.1 Southwest China Endometriosis Drug Market, by Type

    • 12.2 Southwest China Endometriosis Drug Market, by Application

    Chapter 13 Northwest China Endometriosis Drug Market Analysis

    • 13.1 Northwest China Endometriosis Drug Market, by Type

    • 13.2 Northwest China Endometriosis Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 AbbVie

        • 14.1.1 AbbVie Company Profile

        • 14.1.2 AbbVie Endometriosis Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Endoceutics

        • 14.2.1 Endoceutics Company Profile

        • 14.2.2 Endoceutics Endometriosis Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 United Pharmaceuticals

        • 14.3.1 United Pharmaceuticals Company Profile

        • 14.3.2 United Pharmaceuticals Endometriosis Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Roivant Sciences

        • 14.4.1 Roivant Sciences Company Profile

        • 14.4.2 Roivant Sciences Endometriosis Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Pfizer

        • 14.5.1 Pfizer Company Profile

        • 14.5.2 Pfizer Endometriosis Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Neurocrine Biosciences

        • 14.6.1 Neurocrine Biosciences Company Profile

        • 14.6.2 Neurocrine Biosciences Endometriosis Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 SYNG Pharmaceuticals

        • 14.7.1 SYNG Pharmaceuticals Company Profile

        • 14.7.2 SYNG Pharmaceuticals Endometriosis Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 PregLem

        • 14.8.1 PregLem Company Profile

        • 14.8.2 PregLem Endometriosis Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Debiopharm

        • 14.9.1 Debiopharm Company Profile

        • 14.9.2 Debiopharm Endometriosis Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Euroscreen

        • 14.10.1 Euroscreen Company Profile

        • 14.10.2 Euroscreen Endometriosis Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Astellas Pharma

        • 14.11.1 Astellas Pharma Company Profile

        • 14.11.2 Astellas Pharma Endometriosis Drug Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Speciality European Pharma

        • 14.12.1 Speciality European Pharma Company Profile

        • 14.12.2 Speciality European Pharma Endometriosis Drug Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Addex Therapeutics

        • 14.13.1 Addex Therapeutics Company Profile

        • 14.13.2 Addex Therapeutics Endometriosis Drug Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Isifer

        • 14.14.1 Isifer Company Profile

        • 14.14.2 Isifer Endometriosis Drug Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Repros Therapeutics

        • 14.15.1 Repros Therapeutics Company Profile

        • 14.15.2 Repros Therapeutics Endometriosis Drug Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 ElexoPharm

        • 14.16.1 ElexoPharm Company Profile

        • 14.16.2 ElexoPharm Endometriosis Drug Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 AstraZeneca

        • 14.17.1 AstraZeneca Company Profile

        • 14.17.2 AstraZeneca Endometriosis Drug Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 SK Chemicals

        • 14.18.1 SK Chemicals Company Profile

        • 14.18.2 SK Chemicals Endometriosis Drug Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Forendo Pharma

        • 14.19.1 Forendo Pharma Company Profile

        • 14.19.2 Forendo Pharma Endometriosis Drug Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Kissei Pharmaceutical

        • 14.20.1 Kissei Pharmaceutical Company Profile

        • 14.20.2 Kissei Pharmaceutical Endometriosis Drug Market Performance

        • 14.20.3 Product&Service Introduction

      • 14.21 Takeda

        • 14.21.1 Takeda Company Profile

        • 14.21.2 Takeda Endometriosis Drug Market Performance

        • 14.21.3 Product&Service Introduction

      • 14.22 Orphagen Pharmaceuticals

        • 14.22.1 Orphagen Pharmaceuticals Company Profile

        • 14.22.2 Orphagen Pharmaceuticals Endometriosis Drug Market Performance

        • 14.22.3 Product&Service Introduction

      • 14.23 Bayer HealthCare

        • 14.23.1 Bayer HealthCare Company Profile

        • 14.23.2 Bayer HealthCare Endometriosis Drug Market Performance

        • 14.23.3 Product&Service Introduction

      • 14.24 Philogen

        • 14.24.1 Philogen Company Profile

        • 14.24.2 Philogen Endometriosis Drug Market Performance

        • 14.24.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Endometriosis Drug Industry Research Conclusions

    • 15.2 Endometriosis Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Endometriosis Drug Industry Market Size (2018-2029)

    • Figure China Endometriosis Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Endometriosis Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Endometriosis Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Endometriosis Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Endometriosis Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Endometriosis Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Endometriosis Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Endometriosis Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Endometriosis Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Endometriosis Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Endometriosis Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Endometriosis Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Endometriosis Drug Market Size and Growth Rate from 2018-2029

    • Figure Endometriosis Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Endometriosis Drug Market Share by Type in 2018

    • Figure China Endometriosis Drug Market Share by Type in 2023

    • Figure China Endometriosis Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Endometriosis Drug Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Endometriosis Drug Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Endometriosis Drug Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Endometriosis Drug Market Share by Application in 2018

    • Figure China Endometriosis Drug Market Share by Application in 2023

    • Figure China Endometriosis Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Endometriosis Drug Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Endometriosis Drug Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Endometriosis Drug Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Endometriosis Drug Production Volume by Region (2018-2023)

    • Table China Endometriosis Drug Production Volume Share by Region (2018-2023)

    • Figure China Endometriosis Drug Production Volume Share by Region (2018-2023)

    • Table China Endometriosis Drug Production Value by Region (2018-2023)

    • Table China Endometriosis Drug Production Value Share by Region (2018-2023)

    • Figure China Endometriosis Drug Production Value Share by Region (2018-2023)

    • Table China Endometriosis Drug Sales Volume by Region (2018-2023)

    • Table China Endometriosis Drug Sales Volume Share by Region (2018-2023)

    • Figure China Endometriosis Drug Sales Volume Share by Region (2018-2023)

    • Table China Endometriosis Drug Sales Value by Region (2018-2023)

    • Table China Endometriosis Drug Sales Value Share by Region (2018-2023)

    • Figure China Endometriosis Drug Sales Value Share by Region (2018-2023)

    • Table North China Endometriosis Drug Production Volume by Type (2018-2023)

    • Table North China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Figure North China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Table North China Endometriosis Drug Sales Volume by Application (2018-2023)

    • Table North China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Endometriosis Drug Production Volume by Type (2018-2023)

    • Table Central China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Table Central China Endometriosis Drug Sales Volume by Application (2018-2023)

    • Table Central China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Table South China Endometriosis Drug Production Volume by Type (2018-2023)

    • Table South China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Figure South China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Table South China Endometriosis Drug Sales Volume by Application (2018-2023)

    • Table South China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Table East China Endometriosis Drug Production Volume by Type (2018-2023)

    • Table East China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Figure East China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Table East China Endometriosis Drug Sales Volume by Application (2018-2023)

    • Table East China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Endometriosis Drug Production Volume by Type (2018-2023)

    • Table Northeast China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Endometriosis Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Endometriosis Drug Production Volume by Type (2018-2023)

    • Table Southwest China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Endometriosis Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Endometriosis Drug Production Volume by Type (2018-2023)

    • Table Northwest China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Endometriosis Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Endometriosis Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Endometriosis Drug Sales Volume Share by Application (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Endoceutics Company Profile

    • Table Endoceutics Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table United Pharmaceuticals Company Profile

    • Table United Pharmaceuticals Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Roivant Sciences Company Profile

    • Table Roivant Sciences Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Neurocrine Biosciences Company Profile

    • Table Neurocrine Biosciences Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table SYNG Pharmaceuticals Company Profile

    • Table SYNG Pharmaceuticals Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table PregLem Company Profile

    • Table PregLem Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Debiopharm Company Profile

    • Table Debiopharm Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Euroscreen Company Profile

    • Table Euroscreen Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Speciality European Pharma Company Profile

    • Table Speciality European Pharma Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Addex Therapeutics Company Profile

    • Table Addex Therapeutics Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Isifer Company Profile

    • Table Isifer Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Repros Therapeutics Company Profile

    • Table Repros Therapeutics Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table ElexoPharm Company Profile

    • Table ElexoPharm Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table SK Chemicals Company Profile

    • Table SK Chemicals Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Forendo Pharma Company Profile

    • Table Forendo Pharma Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Kissei Pharmaceutical Company Profile

    • Table Kissei Pharmaceutical Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Takeda Company Profile

    • Table Takeda Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Orphagen Pharmaceuticals Company Profile

    • Table Orphagen Pharmaceuticals Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Bayer HealthCare Company Profile

    • Table Bayer HealthCare Endometriosis Drug Revenue, Price and Gross (2018-2023)

    • Table Philogen Company Profile

    • Table Philogen Endometriosis Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US